BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 350780)

  • 1. Analysis of serum blocking factors against leukocyte dependent antibody in melanoma patients.
    Murray E; Ruygrok S; Milton GW; Hersey P
    Int J Cancer; 1978 May; 21(5):578-87. PubMed ID: 350780
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of a low-molecular-weight antigen on melanoma cells by a human antiserum in leukocyte-dependent antibody assays.
    Hersey P; Murray E; Werkmeister J; McCarthy WH
    Br J Cancer; 1979 Oct; 40(4):615-27. PubMed ID: 91379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukemia antigen. II. Purification.
    Billing R; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1639-43. PubMed ID: 4530877
    [No Abstract]   [Full Text] [Related]  

  • 4. Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients.
    Murray E; McCarthy WH; Hersey P
    Br J Cancer; 1977 Jul; 36(1):7-14. PubMed ID: 19029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma.
    Halliday WJ; Maluish AE; Little JH; Davis NC
    Int J Cancer; 1975 Oct; 16(4):645-58. PubMed ID: 51836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of antigenic components of immune complexes isolated from a melanoma patient.
    Cheng WC; Gupta RK; Morton DL
    Immunol Invest; 1985 Aug; 14(4):367-78. PubMed ID: 4065936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine.
    Bystryn JC; Henn M; Li J; Shroba S
    Cancer Res; 1992 Nov; 52(21):5948-53. PubMed ID: 1382848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking factors against melanoma leucocyte-dependent antibody: relationship to disease activity in melanoma patients.
    Hersey P; Murray E; Ruygrok S; Edwards A; Milton GW
    Aust N Z J Surg; 1978 Feb; 48(1):26-32. PubMed ID: 276346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential studies of melanoma leukocyte-dependent antibody activity in melanoma patients.
    Hersey P; Edwards AE; Murray E; McCarthy WH; Milton GW
    Eur J Cancer (1965); 1978 Jun; 14(6):629-37. PubMed ID: 658086
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunodiagnosis of human melanoma: characterization of human melanoma antigens and their detection in sera of melanoma patients by radioimmunoassay.
    Ishii Y; Mavligit GM
    Oncology; 1982; 39(1):23-8. PubMed ID: 6173826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface antigenic characteristics of human melanoma cells defined by xenoantiserum raised against papain-solubilized melanoma-associated antigens.
    Ishii Y; Goldhofer W; Mavligit GM
    Gan; 1980 Dec; 71(6):881-8. PubMed ID: 7024033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of carcinoembryonic-like antigen on melanoma cells by leucocyte-dependent-antibody assays.
    Morgan G; McCarthy WH; Hersey P
    Br J Cancer; 1977 Oct; 36(4):446-52. PubMed ID: 73378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological and immunochemical analysis of the specificity of xenoantiserum 8986 elicited with hybrids between human melanoma cells and murine fibroblasts.
    Imai K; Galloway DR; Ferrone S
    Cancer Res; 1981 Mar; 41(3):1028-33. PubMed ID: 6161692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cell-mediated cytotoxicity for human monolayer target cells bearing blood group and transplantation antigens and for melanoma cells.
    Kodera Y; Bean MA
    Int J Cancer; 1975 Oct; 16(4):579-92. PubMed ID: 1080751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of leukocyte-dependent antibody activity in melanoma patients.
    Hersey P; Edwards A; Murray E; McCarthy WH; Milton GW
    J Natl Cancer Inst; 1983 Jul; 71(1):45-53. PubMed ID: 6575208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid dual-column chromatographic assay for recombinant leukocyte interferon alpha-2.
    Rybacek L; D'Andrea M; Tarnowski SJ
    J Chromatogr; 1987 Jun; 397():355-64. PubMed ID: 3308936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera.
    Hersey P; Honeyman M; Edwards A; Adams E; McCarthy WH
    Int J Cancer; 1976 Nov; 18(5):564-73. PubMed ID: 62719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and partial characterization of melanoma-associated antigens identified by autologous antibody.
    Vlock DR; Scalise D; Meglin N; Kirkwood JM; Ballou B
    J Clin Invest; 1988 Jun; 81(6):1746-51. PubMed ID: 3384949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.